A Dose of Good News for ImClone; Shares soared Tuesday after a study showed the company's Erbitux could be effective against a form of lung cancer

Subjects

Subjects :

Diagnostic reagents industry -- Securities
Diagnostic reagents industry -- Forecasts and trends
Market trend/market analysis
Company securities
ImClone Systems Inc. -- Forecasts and trends
ImClone Systems Inc. -- Securities

Details

Language :

English

Database :

Gale General OneFile

Journal :

Business Week Online

Publication Type :

Periodical

Accession number :

edsgcl.168600039